I. Introduction
In the past years, there has been an increase in the use of microbead-based immunoagglutination assays for the detection of diverse chemicals and biomarkers [1]–[3]. A large array of tests and assays are commercially available, capable of probing infectious diseases, viral and bacterial loads, as well as proteins and biomarkers [4]. Immunoagglutination assays typically consist of beads, in the scale of a few microns, that have been functionalized with with an antibody. These beads, in the presence of a matching antigen, will bind to each other and aggregate, resulting in clumps that are visible to the naked eye. Their simplicity result in robust protocols, and are a good alternative to enzime-linked immunoabsorbent assays (ELISA) [5], which typically require several washing steps and more time-consuming protocols.